{"product_id":"global-next-generation-sequencing-on-drug-development-market","title":"Global Next-Generation Sequencing on Drug Development Market","description":"\u003cp\u003eGlobal Next-Generation Sequencing on Drug Development Market\u003c\/p\u003e\n\n\u003cp\u003eReport Scope:\u003c\/p\u003e\n\n\u003cp\u003eThe scope of this report includes NGS technologies, applications, industries, initiatives, patents and companies. The markets for NGS in drug development are given for 2020, 2021, 2022, 2023 and 2028.\u003c\/p\u003e\n\n\u003cp\u003eThis report reviews the NGS technologies and explains why NGS is important in drug development. It then discusses some of the significant research initiatives that impact NGS. The main market-driving forces are also discussed.\u003c\/p\u003e\n\n\u003cp\u003eThis report examines the markets by product type, end user and region. This report provides market data and forecasts for NGS by product type, including instruments, consumables and services for drug development.\u003c\/p\u003e\n\n\u003cp\u003eSpecific geographic markets are discussed, including North America, Europe, Asia-Pacific and the Rest of the World.\u003c\/p\u003e\n\n\u003cp\u003eBCC Research summarizes the main industry acquisitions and strategic alliances from Jan. 2020, through Dec. 2022, including key alliance trends.\u003c\/p\u003e\n\n\u003cp\u003eReport Includes:\u003c\/p\u003e\n\n\u003cp\u003e52 data tables and 39 additional tables\u003c\/p\u003e\n\n\u003cp\u003eAn overview of the global markets for next-generation sequencing on drug development\u003c\/p\u003e\n\n\u003cp\u003eEstimation of market size and analyses of global market trends, with data from 2020-2022, estimates for 2023, and projections of compound annual growth rates (CAGRs) through 2028\u003c\/p\u003e\n\n\u003cp\u003eHighlights of the market potential and characterization of next-generation sequencing on drug development market by product, service, end-user type, and region\u003c\/p\u003e\n\n\u003cp\u003eExamination of the key drivers and constraints that will shape the market for next-generation sequencing on drug development and discussion on the upcoming market opportunities and areas of focus to forecast the market into various segments and subsegments\u003c\/p\u003e\n\n\u003cp\u003eCoverage of recent advances, emerging technologies, and developments of the industry\u003c\/p\u003e\n\n\u003cp\u003eEvaluation of key industry acquisitions and strategic alliances and market share analysis of the leading suppliers of the industry\u003c\/p\u003e\n\n\u003cp\u003eProfiles of the key companies of the industry, including 10x Genomics, Bio-Rad Laboratories Inc., Oxford Nanopore Technologies, Qiagen and Takara Bio Inc.\u003c\/p\u003e\n\n\u003cp\u003eCompanies Mentioned\u003c\/p\u003e\n\n\u003cp\u003e10X GENOMICS\u003cbr\u003e\nAGILENT TECHNOLOGIES INC.\u003cbr\u003e\nBGI (Beijing Genomics Institute)\u003cbr\u003e\nBIO-RAD LABORATORIES INC.\u003cbr\u003e\nCD GENOMICS\u003cbr\u003e\nILLUMINA INC.\u003cbr\u003e\nINTEGRATED DNA TECHNOLOGIES INC.\u003cbr\u003e\nMicronoma\u003cbr\u003e\nNEW ENGLAND BIOLABS\u003cbr\u003e\nOXFORD NANOPORE TECHNOLOGIES\u003cbr\u003e\nPACIFIC BIOSCIENCES OF CALIFORNIA INC.\u003cbr\u003e\nPERKINELMER INC.\u003cbr\u003e\nPRECISION FOR MEDICINE, FORMERLY APOCELL\u003cbr\u003e\nPROMEGA CORP.\u003cbr\u003e\nPsomagen Inc.\u003cbr\u003e\nQIAGEN\u003cbr\u003e\nROCHE HOLDING AG\u003cbr\u003e\nTAKARA BIO INC.\u003cbr\u003e\nTECAN GROUP LTD.\u003cbr\u003e\nTHERMO FISHER SCIENTIFIC INC.\u003c\/p\u003e","brand":"Life Science","offers":[{"title":"August, 2023 \/ 177 Pages \/ MCW16232111","offer_id":47647469306162,"sku":null,"price":6600.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.hardmanwell.com\/products\/global-next-generation-sequencing-on-drug-development-market","provider":"HARDMAN AND WELL MANAGEMENT CONSULTANCIES L.L.C","version":"1.0","type":"link"}